Public Health Global

Global Dengue Public Health Report

Updated Reviewed by Chandani Patel

Global Dengue Public Health Report: Disease Burden, Demographic and Geographic Distribution, Risk Factors, Screening and Diagnosis, Treatment Coverage, Programmes, Gaps and Outlook

Public Health Dashboard · published data

Dengue worldwide: key statistics

Global
Latest published figures for the countries in this report
Country Basic toilets (sanitation)of peopleBasic drinking waterof peopleExtreme povertyof peopleHealth spending from abroadof health spending
Bangladesh 68% 2024 99% 2024 5.9% 2022 3.5% 2023
India 83% 2024 96% 2024 2.6% 2023 2.4% 2023
Indonesia 88% 2024 89% 2024 3.7% 2025 0.6% 2023
Myanmar 74% 2024 86% 2024 10.3% 2017 6.1% 2023
Pakistan 72% 2024 91% 2024 23.0% 2024 9.7% 2023
Philippines 87% 2024 96% 2024 11.5% 2023 0.1% 2023
Saudi Arabia 98% 2024 99% 2024 — 0.0% 2023
Sudan 66% 2024 65% 2024 — 16.3% 2023

Sources: World Bank, Our World in Data. A dash means no recent published figure.

Only published figures are shown here, with their year and source. The full report keeps reported cases, survey estimates and modelled estimates apart, and names the data gaps.

Buy the full report

Report snapshot

Global Dengue Public Health Report at a glance
TopicDengue
PlaceGlobal
Basic toilets (sanitation) (latest)82% of people (2024)Source: World Bank Open Data, Basic toilets (sanitation) (% of people). Retrieved 19 Nov 2026.
Report sections16 (table of contents)
Active clinical trials52 worldwideSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
FormatsPDF, PPTX, XLSX

Global Dengue: Overview and Epidemiological Profile

Dengue is a mosquito-borne viral infection that is spreading fast with climate change and urbanisation, and severe dengue can cause bleeding and shock. This report covers dengue without warning signs, dengue with warning signs and severe dengue.

Burden: Prevalence, Incidence and Mortality

The report sets out the prevalence, incidence and, where relevant, deaths from dengue worldwide, and the overall burden, using Population Requiring Interventions, Mass Drug Administration Coverage, Reported Cases, Disability From NTDs and Elimination Status.

Demographic Distribution: Age, Gender and Vulnerable Population Groups

The burden is broken down by age (pre-school children, school-age children, adolescents, adults and older adults), gender and income, with a focus on rural poor communities, school-age children, women and girls, farmers and fishers, remote and nomadic communities and people living with NTD-Related disability.

Geographical Distribution: State, District, Urban and Rural Segmentation

Findings are compared across states, provinces and districts where data allows, and between urban, rural and informal settlement areas, to show where needs are greatest and where gaps between places are widest.

Risk Factors and Social Determinants of Health

Main risk factors include poverty, unsafe water and sanitation, contact with vectors, living near rivers and forests, poor housing and limited health services. Income, education, housing, water and sanitation, and gender and social norms are reviewed as social drivers of health.

Awareness and Screening Coverage

The report reviews how aware people are of dengue and how far screening reaches them, through mapping and prevalence surveys, community case detection, rapid diagnostic tests and skin and eye examinations, by group and by area.

Diagnosis Rates and Undiagnosed Burden

It compares the number of people diagnosed with the estimated number affected, to show the undiagnosed burden and how many people are lost between screening and treatment.

Treatment, Prevention and Coverage

Treatment and prevention covered include clinical fluid management, aedes mosquito control, wolbachia mosquito releases and dengue vaccines, with how many people receive treatment and how many stay on it.

Health Outcomes and Complications

Long-term effects covered include disability and disfigurement, blindness, stigma and exclusion and lost schooling and income, along with other conditions that often occur alongside dengue.

Healthcare Infrastructure and Accessibility

The report looks at primary health care, community drug distributors, laboratory and mapping teams and donated medicine supply chains, the health workforce, and the physical, financial and distance barriers to care, including how people use public and private services.

Economic and Socioeconomic Burden

Dengue worldwide: health cover, spending and research

WHO reports that 4.5 billion people were not fully covered by essential health services in 2021.⁠[1] The world scores 71 out of 100 on the WHO universal health coverage index (2023).⁠[2] People pay 17.3% of all health spending out of their own pockets (2023).⁠[3] ClinicalTrials.gov lists 52 studies on Dengue that are recruiting, active or about to start worldwide.⁠[4]

[1] World Health Organization, universal health coverage. Checked 14 Nov 2026.

[2] WHO Global Health Observatory, Universal health coverage index (index (0–100)). Retrieved 21 Nov 2026.

[3] World Bank Open Data, Out-of-pocket spending (% of health spending). Retrieved 20 Nov 2026.

[4] ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.

It describes the costs of dengue to health systems and households, including out-of-pocket spending and lost productivity, and how government, donors and NGOs fund the response.

Government Initiatives and Public Health Interventions

Worldwide guidance and funding for dengue include WHO NTD Road Map 2021–2030, Kigali Declaration on Neglected Tropical Diseases, Pharmaceutical Medicine Donation Programmes and Expanded Special Project for Elimination of NTDs (ESPEN). The report reviews national programmes, donor and NGO funding, and what is known about their impact.

Historical Trends and Comparative Analysis

Year-wise trends and changes across survey rounds are shown and compared with peer countries, with the data collection year and reporting period stated for each figure.

Healthcare Gaps and Unmet Needs

The report names gaps in screening, diagnosis, treatment and access, the high-risk and underserved communities most affected, and where reliable data is missing.

Future Burden and Public Health Outlook

It looks ahead at the likely future burden of dengue, the healthcare it will need and the areas most vulnerable.

Key Findings and Strategic Recommendations

The report closes with key findings, the population groups to prioritise and recommendations on where to target resources. Figures come from WHO Global Health Observatory NTD Data, ESPEN Portal, National NTD Programme Data and Global Burden of Disease (IHME). Reported cases, survey estimates and modelled estimates are kept apart, and missing figures are named as data gaps.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Dengue Public Health Report right now, from free public sources.

Clinical trials

52 active trials worldwide

Recruiting, about to start, or running now.

Top trial sponsors (worldwide)

  1. Takeda Pharmaceutical Company Ltd 5 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Sanofi 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

See every trial on ClinicalTrials.gov (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 19 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Dengue Public Health Report in context

Free data on this topic

Quick answers

Frequently asked questions

What is dengue?
Dengue is a mosquito-borne viral infection that is spreading fast with climate change and urbanisation, and severe dengue can cause bleeding and shock. This report covers dengue without warning signs, dengue with warning signs and severe dengue.
What does the report on dengue worldwide cover?
The report has 16 sections: overview and epidemiological profile; burden; demographic distribution; geographical distribution; risk factors and social determinants of health; awareness and screening coverage; diagnosis rates and undiagnosed burden; treatment, prevention and coverage; health outcomes and complications; healthcare infrastructure and accessibility; economic and socioeconomic burden; government initiatives and public health interventions; historical trends and comparative analysis; healthcare gaps and unmet needs; future burden and public health outlook; key findings and strategic recommendations.
How good is health coverage worldwide?
The world scores 71 out of 100 on the WHO universal health coverage index (2023). Source: WHO Global Health Observatory, Universal health coverage index. Retrieved 21 Nov 2026.
How much of health spending do people pay themselves worldwide?
People pay 17.3% of all health spending out of their own pockets (2023). Source: World Bank Open Data, Out-of-pocket spending. Retrieved 20 Nov 2026.
How is healthcare paid for worldwide?
WHO reports that 4.5 billion people were not fully covered by essential health services in 2021. Source: World Health Organization, universal health coverage. Checked 14 Nov 2026.
How many clinical trials on dengue are running worldwide?
52 studies are recruiting, active or about to start worldwide, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, worldwide. Retrieved 12 Nov 2026.
Back to Catalogue

Related Public Health reports in Global

See all

Related on infectious diseases

See the topic